Director/PDMR Shareholding

RNS Number : 7325D

Hikma Pharmaceuticals Plc

28 April 2017

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Khalid Nabilsi
2	Reason for the notification
a)	Position/status	Chief Financial Officer
b)	Initial notification /Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Hikma Pharmaceuticals PLC
b)	LEI	549300BNS685UXH4JI75
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument and identification code	Description: Ordinary shares of 10 pence each (Shares) ID Code: GB00B0LCW083
b)	Nature of the transaction	Disposal of 19,500 Ordinary Shares of 10 pence each in Hikma Pharmaceuticals PLC.
c)	Price(s) and volume(s)	Price(s): £19.36 Volume(s): 19,500
d)	Aggregated information	Volume: 19,500 Price: £19.36 Total: £377,520.00
e)	Date of the transaction	28 April 2017
f)	Place of the transaction	London Stock Exchange (XLON)

 

END

 

 

DSHBXGDSIBDBGRI